MedTrace Logo

Study of Individuals Affected With Hypoplasminogenemia

NCT03797495 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-08-28

No results posted yet for this study

Summary

This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expression, identify markers to predict disease course, and inform improved therapeutic modalities

Conditions

  • Plasminogen Deficiency

Sponsors & Collaborators

  • Fondazione Angelo Bianchi Bonomi

    collaborator OTHER

  • Indiana Hemophilia &Thrombosis Center, Inc.

    lead OTHER

Principal Investigators

  • Amy D Shapiro, MD · Indiana Hemophilia &Thrombosis Center, Inc.

  • Flora Peyvandi, MD, PhD · Univeristy of Milan

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2027-03-08
Completion
2027-04-19

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Canada
  • Greece
  • Israel
  • Italy
  • Thailand
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797495 on ClinicalTrials.gov